top of page
TAGS
Psychiatry
Clinical Strategies on Prescribing Long-acting Injectable Antipsychotics in Managing Schizophrenia
Schizophrenia is a psychiatric syndrome of delusions, disorganised speech, hallucinations, and impaired executive functioning1. Despite affecting approximately 1% of the global population, poor treatment adherence remains as an unmet need associated...
Aug 20, 2024
Breaking Through the Treatment-Resistance Depression with Esketamine
Major depressive disorder (MDD) is highly prevalent and affects more than 264 million individuals, globally. Remarkably, despite treatment, up to half of the patients with depression fail to reach remission and are at risk of experiencing treatment-...
Aug 20, 2024
LEQEMBI®
LEQEMBI® (lecanemab) EISAI HK Reg. No. HK-68289 (03 Jul, 2024) & HK-68290 (03 Jul, 2024) Composition: 3 LEQEMBI® is an amyloid beta-directed antibody with the active ingredient lecanemab-irmb. It is administered as an intravenous infusio...
Aug 20, 2024
Clinical Trial Snapshot - Slimming Down and Sobering Up – Fight Alcohol Cravings with Semaglutide
Apr 11, 2025
What Should We Know About Anxiety Disorder?
Anxiety disorders are one of the most prevalent psychiatric disorders, up to 30% of the population are reported to be affected by an anxiety disorder during their lifetime. While anxiety disorders are associated with a significant disease burden and...
Apr 11, 2025
New Horizons in Treatment-Resistant Schizophrenia
Clozapine is the only approved treatment for patients with treatment-resistant schizophrenia (TRS) but response rates remain at 50 – 60% 1 . Evenamide, a sodium channel blocker, has shown efficacy in a phase II trial to significantly reduce sy...
Jun 13, 2025
The Management of Treatment-resistant Bipolar Disorder and Generalised Anxiety Disorder— A Systematic Review
The disease burden of mental disorders has become increasingly relevant as this causes a high degree of individual and social suffering, whereas mood and anxiety disorders are commonly involved. Previous pooled analysis suggested that the lifetime p...
Oct 24, 2025
DESPAXOR
DESPAXOR ® (desvenlafaxine, as succinate) SYNCO HK Reg. No. HK-68803, HK-68804 (07 Aug, 2025) Composition: 1 • DESPAXOR is available in the following dosage forms: 50 mg and 100 mg extended-release oral tablets • Each tablet contains 7...
Oct 24, 2025
Voices in the Mind: Schizophrenia Hallucinations and Misidentified Inner Speech
New research suggests that auditory hallucinations in schizophrenia may occur when the brain fails to recognize its own “inner speech”, the silent voice most people use to think. Researchers compared EEG recordings between schizophrenic ...
Dec 19, 2025
Risk of Gambling-Related Suicidal Ideation
Among 2,800 help-seekers for gambling-related problems in Finland, women demonstrated significantly higher rates of suicidal ideation compared to men (25.5% versus 16.4%), with gambling-related debts and inadequate social support identified as criti...
Feb 11, 2026
Methylphenidate Use in ADHD Children's Growth
Children diagnosed with ADHD, particularly those receiving long-term methylphenidate treatment, demonstrated higher body mass index (BMI) and reduced height at adulthood compared to individuals without ADHD. This matched cohort study examined growth...
Feb 11, 2026
ZOLOFT®
ZOLOFT ® (sertraline, as hydrochloride) VIATRIS HK Reg. No. HK-68926 (09 Dec, 2025) Composition: 3 ZOLOFT ® is available in 100 mg tablets, along with other dosage forms Indication: 3 ZOLOFT ® is a selective serotonin reuptake inhibitor ...
Feb 11, 2026
POPULAR STORY

Uncovering the Tricks of the Silent Thief of Sight
Dr. Roy Lau
Dec 19, 2024

What’s New in Coronary Artery Disease?
Dr. Roy Lau
Aug 20, 2024

Challenges and Strategies for Managing CHB Patients with Co-morbidities
Dr. Roy Lau
Jun 21, 2024

Decoding the Paradox on Impact of Obesity on Cognitive Functioning
Dr. Roy Lau
Jun 20, 2024

Gain Without Pain – Revisiting the Pain Management in Rheumatoid Arthritis
Dr. Roy Lau
Oct 22, 2024

Uncovering the Art of Perfect Matching – A Review on Precision Oncology
Dr. Roy Lau
Feb 17, 2025
bottom of page
.png)